Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric J Small

Showing results (41-50 of 361) with videos related to

Pageof 37
Sort By:
Seminars in Urologic Oncology|August 29, 2002
Secondary hormonal manipulation of prostate cancerEric J Small, Katherine A Harris
Nature Reviews. Cancer|December 3, 2002
Bloodborne biomolecular markers in prostate cancer development and progressionRobert A Bok, Eric J Small
Drugs of Today (Barcelona, Spain : 1998)|June 10, 2008
Sipuleucel-T for the treatment of prostate cancerAndrea L Harzstark, Eric J Small
Contemporary Clinical Trials|April 10, 2020
Does the COVID-19 outbreak identify a broader need for an urgent transformation of cancer clinical trials research?Hala T Borno, Eric J Small
Current Treatment Options in Oncology|August 27, 2002
Hormone-refractory Prostate CancerBrian I Rini, Eric J Small
The Journal of Urology|November 7, 2006
High risk biochemical relapse and the timing of androgen deprivation therapyCharles J Ryan, Eric J Small
The Journal of Urology|November 7, 2006
The case for secondary hormonal therapies in the chemotherapy ageEric J Small, Charles J Ryan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2011
Prostate cancer: evolution or revolution?Eric J Small, Johann Sebastian de Bono
Clinical Prostate Cancer|March 30, 2004
Liposomal doxorubicin for the treatment of hormone-refractory prostate cancerKatherine A Harris, Elaine Harney, Eric J Small
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2014
Reply to F. Valcamonico et alMatthew R Smith, Susan Halabi, Eric J Small
Pageof 37

Showing results (41-50 of 361) with videos related to

Sort By:
Pageof 37
Seminars in Urologic Oncology|August 29, 2002
Secondary hormonal manipulation of prostate cancerEric J Small, Katherine A Harris
Nature Reviews. Cancer|December 3, 2002
Bloodborne biomolecular markers in prostate cancer development and progressionRobert A Bok, Eric J Small
Drugs of Today (Barcelona, Spain : 1998)|June 10, 2008
Sipuleucel-T for the treatment of prostate cancerAndrea L Harzstark, Eric J Small
Contemporary Clinical Trials|April 10, 2020
Does the COVID-19 outbreak identify a broader need for an urgent transformation of cancer clinical trials research?Hala T Borno, Eric J Small
Current Treatment Options in Oncology|August 27, 2002
Hormone-refractory Prostate CancerBrian I Rini, Eric J Small
The Journal of Urology|November 7, 2006
High risk biochemical relapse and the timing of androgen deprivation therapyCharles J Ryan, Eric J Small
The Journal of Urology|November 7, 2006
The case for secondary hormonal therapies in the chemotherapy ageEric J Small, Charles J Ryan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2011
Prostate cancer: evolution or revolution?Eric J Small, Johann Sebastian de Bono
Clinical Prostate Cancer|March 30, 2004
Liposomal doxorubicin for the treatment of hormone-refractory prostate cancerKatherine A Harris, Elaine Harney, Eric J Small
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2014
Reply to F. Valcamonico et alMatthew R Smith, Susan Halabi, Eric J Small
Pageof 37